PEXA is not a high quality stock because the high quality Australian segment is hampered by the International and Digital segments.

From fat-loss fad to preventative medicine for a range of chronic health conditions that result from obesity and other metabolic conditions.

Over the last couple of weeks, I have received multiple requests for comment on a small speculative radiology software stock called 4D Medical (ASX: 4DX), in part because it announced on July 31, 2025 ...

Lovisa Holdings (ASX: LOV) delivered another year of strong global growth in FY 2025, setting the stage for further expansion going forward.

I’ve written about IPD Group (ASX: IPG) several times over the last few months, both here on A Rich Life, and on Livewire Markets. I purchased shares in IPD Group between February and April of this ...

Should negative gearing be disallowed for short-stay rental homes? That’s the argument behind a new housing affordability campaign by homelessness advocacy group, Everybody’s Home. Everybody’s Home ...

A company I have covered many times for this publication, Vysarn (VYS:ASX) reported their FY 2025 earnings on Friday, with headline numbers looking relatively strong off the back of what was a ...

A spate of recent Australian cases where AI use by lawyers has created false case citations heralds a new era of legal issues for courts.

I am writing a quick note on why I bought Codan (ASX: CDA) shares, because even though I have followed the company for many years, I haven’t covered it on these pages. As a quick primer, Codan is a ...

Now, as bad as it seems, the above result was expected, and the market was well informed about it prior to these results, so I don’t think these numbers drove the share price decline from around $6 ...